# Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release Formulation

> **NCT01841086** · PHASE1 · COMPLETED · sponsor: **Korea United Pharm. Inc.** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Anplag
- **DRUG:** UI03SPG300CT

## Key facts

- **NCT ID:** NCT01841086
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2013-04-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01841086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01841086, "Pharmacokinetics and Food Effect of Sarpogrelate HCl CR Formulation in Comparison to Immediate-release Formulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01841086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*